Pharmaceutical

BeiGene is planning to break ground in 2022 on a pharmaceutical manufacturing and research center in Hopewell, N.J. Located on the Princeton West Innovation Campus, the integrated complex will provide 400,000 sf of dedicated space for commercial-stage production of innovative cancer therapies. Offering up to 16,000 liters of biologics capacity, the facility will also include clinical R&D labs and collaborative office environments. IPS is the architect and engineer for the project, which will be built by DPR Construction.

AstraZeneca opened The Discovery Centre in November of 2021 in the United Kingdom. Designed by Herzog & de Meuron and BDP, the £1 billion R&D facility can accommodate over 2,200 investigators engaged in the creation of next-generation therapeutics and innovative precision medicines. Integrating advanced robotic and AI-driven technologies, the 580,000-sf project is strategically sited on the Cambridge Biomedical Campus to promote collaboration and convergence with neighboring institutions and industry partners. 

East Carolina University opened the $90 million Life Sciences and Biotechnology Building in November of 2021 in Greenville, N.C. Designed by Lord Aeck Sargent, the 141,500-sf facility provides leading-edge wet and dry labs for programs in biotechnology, bioprocessing engineering, biophysics, environmental engineering, biofuels, plant biology, environmental biology, and imaging and sensor development.

Autolus Therapeutics broke ground in November of 2021 on a £66 million cell manufacturing facility in Stevenage in the United Kingdom. Accommodating the production of chimeric antigen receptor T-cells for the treatment of cancer, the 80,730-sf project is being built by Merit using modular offsite construction methodology to significantly accelerate the construction timeline and reduce carbon emissions.

Amgen broke ground in November of 2021 on a $365 million biomanufacturing plant in New Albany, Ohio. Created by the design-build team of CRB and Turner Construction, the smart factory will leverage advanced automation technologies to optimize the assembly and packaging of injectable medicines. The 270,000-sf facility will accommodate 400 new employees and an array of collaborative and industrial robots.

Vermeulens has released its market outlook report for the third quarter of 2021. Key points include:

Sterling Bay began construction in October of 2021 on a 320,000-sf life sciences center in Chicago. Designed by Gensler, the eight-story ALLY building will provide leading-edge lab and office environments for biomedical and pharmaceutical tenants. With 15’ floor-to-floor heights, the 280,000-rsf project will offer flexible floor plates of approximately 42,000 sf.

FUJIFILM Diosynth Biotechnologies broke ground in October of 2021 on a $2 billion production facility in Holly Springs, N.C. Enabling large-scale cell culture manufacturing for the creation of bulk drug substances, the structure will accommodate eight 20,000-liter bioreactors with the expansion potential for a further 24 20,000-liter bioreactors to meet market demand. Powered by clean energy, the sustainably designed complex will feature advanced systems for waste disposal and recycling.

Moderna is partnering with Alexandria Real Estate Equities to create a 462,000-rsf headquarters and research facility at the Alexandria Center development at One Kendall Square. Accelerating the discovery and development of mRNA vaccines and therapeutics, the collaborative structure will feature leading-edge R&D labs, sophisticated offices, and engaging gathering spaces.

AstraZeneca is planning to construct a $360 million manufacturing center in the Blanchardstown region of Dublin. Located on the Alexion Campus in College Park, the next-generation facility will leverage advanced process technologies and digital innovation solutions to produce small-molecule APIs (active pharmaceutical ingredients). Significantly reducing commercialization lead times, the sustainably designed structure will integrate lean manufacturing practices to lower operating costs and reduce carbon emissions.

Tonix Pharmaceuticals broke ground in August of 2021 on the 45,000-sf Advanced Development Center in Dartmouth, Mass. Enabling the production of clinical-stage vaccines for COVID-19 and other infectious diseases, the BSL-2 facility will utilize single-use bioreactors and purification suites for optimal efficiency and flexibility. The cGMP center will also offer state-of-the-art research, development, and analytical suites. Approximately 70 scientists, technicians, and manufacturing staff will work in the turnkey building. 

Ivanhoé Cambridge and Lendlease will break ground in summer of 2022 on a 320,000-sf life sciences facility in Boston. Designed by SGA, the nine-story building will provide state-of-the-art labs, offices, and collaboration spaces for biomedical and pharmaceutical tenants. Offering BSL-1 and BSL-2 research environments, the amenity-rich structure will include a multipurpose ground floor, a parking garage, and numerous outdoor areas.

The University of Maryland broke ground in August of 2021 on the $116 million Chemistry Building in College Park. Designed by Ballinger, the flexible 105,000-sf structure will provide 34 modular research labs with robust climate controls and vibration mitigation technologies. Accelerating innovation in advanced materials, nanoscience, energy storage, quantum chemistry, and drug discovery and delivery, the project will include two core facilities, 12 meeting and huddle rooms, open office environments, and 13,000 sf of collaboration space.

The Fitzsimons Innovation Community broke ground in August of 2021 on Bioscience 5 in Aurora, Colo. Strategically located next to the University of Colorado Anschutz Medical Campus, the 90,000-sf building will enable biomedical and pharmaceutical tenants to manufacture next-generation cell and gene therapy products on a commercial scale. Saunders Construction is the general contractor for the highly flexible facility, which is slated for occupancy in spring of 2022.

The Davis Companies and Boston Development Group broke ground in August of 2021 on a purpose-built life sciences building in Watertown, Mass. The joint-venture project will offer 224,000 rsf of Class A research space for biomedical and pharmaceutical tenants. Designed by Elkus Manfredi Architects, the facility will provide next-generation laboratories, offices, a fitness center, a shared rooftop balcony, six private outdoor areas, and ample indoor parking accessible directly beneath the building.